Department of Medicine, Surgery and Neuroscience, Division of Vascular Surgery, University of Siena, Siena, Italy.
Department of Medicine, Surgery and Neuroscience, Division of Vascular Surgery, University of Siena, Siena, Italy.
Ann Vasc Surg. 2021 May;73:107-113. doi: 10.1016/j.avsg.2021.02.003. Epub 2021 Mar 6.
The novel acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic imposed a national lockdown at the beginning of 2020. People faced social distancing, being forced to stay at home. Peripheral arterial disease (PAD) typically influences life habits and psycho-social relationship. It is now questionable how PAD can be affected by changes in lifestyle imposed by the Sars-CoV-19 Pandemic. This study's main objective is to evaluate how the limitations of social behavior set by Sars-CoV-19 Pandemic impact the perception and evolution of the disease in a group of patients with a diagnosed PAD.
The changes in the in the perception and the evolution of the PAD were evaluated by comparing results of a modified VascuQol-6 quality of life (QoL) survey referring to the time frame defined "No-Sars-CoV-2 period" (from July to December 2019) with results referring to the time frame defined "Sars-CoV-2 period" (from January to June 2020). An overall score (range 4-60) was calculated, and a comparison between the two period studies was reported. Receiver Operating Characteristics (ROC) Curves evaluated a delta value for each patient with revascularization of lower limb peripheral arteries. Optimal cut-offs were chosen based on their specificity, sensitivity.
One-hundred-two PAD patients gave their informed consent to take part in the study. A significant general worsening of patients PAD perception in the Sars-CoV-2 period was recorded for the following items: lower limbs health status perception; overall activity limitation; walking ability limitation; overall daily walking distance; lower limbs fatigue perception; concerns about PAD worsening; pain discomfort (P < 0.05). The pain intensity changed from 4.7 ± 2.9 in the No-Sars-CoV-2 period to 6.3 ± 2.9 in the Sars-CoV-2 period significantly (P < 0.0001), even though analgesic drug intake did not increase considerably in Sars-CoV-2 period (P = 0.15). The overall score was 20.3 ± 7.4 for the No-Sars-CoV-2 period and 27.4 ± 7.6 in the Sars-CoV-2 period (P = 0.0001). The ROC curve built to analyze the relation between Delta-score and the need for revascularization identifies a cut-off > 8.5 (Area Under the Curve 0.5436; CI 95% 0.4252 to 0.6620) with a sensitivity and specificity respectively of 52.6% (CI 95% 37.26-67.52%) and 65.6% (CI 95% 53.40-76.08%).
Patients with PAD were significantly hit by all the restrictions and the social limitations imposed to reduce the Sars-CoV-19 virus diffusion. Our study confirms that the perception and the evolution of PAD were significantly affected during the "Sars-CoV-2 period".
新型严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)大流行于 2020 年初实施了全国封锁。人们被迫保持社交距离,留在家中。外周动脉疾病(PAD)通常会影响生活习惯和心理社会关系。现在,人们质疑 SARS-CoV-19 大流行期间生活方式的改变会如何影响 PAD。本研究的主要目的是评估 Sars-CoV-19 大流行期间社交行为的限制如何影响一组确诊 PAD 患者对疾病的认知和演变。
通过比较指称“无 SARS-CoV-2 时期”(2019 年 7 月至 12 月)的改良 VascuQol-6 生活质量(QoL)调查结果与指称“SARS-CoV-2 时期”(2020 年 1 月至 6 月)的结果,评估了 PAD 认知和演变的变化。计算了总体评分(范围为 4-60),并报告了两个时间段研究之间的比较。接收器操作特性(ROC)曲线为下肢外周动脉再血管化的每位患者评估了一个差值。根据其特异性和敏感性选择最佳截断值。
102 名 PAD 患者同意参加这项研究。在 Sars-CoV-2 期间,患者 PAD 认知的以下方面记录到明显的总体恶化:下肢健康状况认知;整体活动受限;行走能力受限;日常整体行走距离;下肢疲劳认知;对 PAD 恶化的担忧;疼痛不适(P<0.05)。疼痛强度从无 SARS-CoV-2 时期的 4.7±2.9 显着增加到 SARS-CoV-2 时期的 6.3±2.9(P<0.0001),尽管 SARS-CoV-2 时期阿片类药物的摄入量并没有显着增加(P=0.15)。无 SARS-CoV-2 时期的总体评分为 20.3±7.4,Sars-CoV-2 时期为 27.4±7.6(P=0.0001)。为分析 Delta 评分与再血管化需求之间的关系而构建的 ROC 曲线确定了>8.5 的截断值(曲线下面积 0.5436;95%CI 0.4252 至 0.6620),其灵敏度和特异性分别为 52.6%(95%CI 37.26%至 67.52%)和 65.6%(95%CI 53.40%至 76.08%)。
PAD 患者受到所有旨在减少 SARS-CoV-19 病毒传播的限制和社交限制的严重打击。我们的研究证实,在“Sars-CoV-2 时期”,PAD 的认知和演变受到了明显影响。